Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act.
JAMA
; 328(15): 1502-1503, 2022 10 18.
Article
in En
| MEDLINE
| ID: mdl-36255438
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Medicare
/
Health Expenditures
/
Fee-for-Service Plans
/
Drug Industry
/
Inflation, Economic
Limits:
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
JAMA
Year:
2022
Document type:
Article
Country of publication: